Bionano Genomics, Inc. SEC filings BNGO
Bionano Genomics, Inc. has 629 filings in SEC EDGAR's recent list, going back to Aug 31, 2007. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 2, 2026 | — |
| DEF 14A | Proxy statement | Apr 2, 2026 | Apr 1, 2026 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 11, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Jun 11, 2025 |
| DEFA14A | Additional proxy material | Dec 19, 2024 | — |
| DEFA14A | Additional proxy material | Dec 5, 2024 | — |
| DEF 14A | Proxy statement | Dec 5, 2024 | Jan 15, 2025 |
| PRE 14A | Preliminary proxy statement | Nov 25, 2024 | Jan 15, 2025 |
| DEFA14A | Additional proxy material | Oct 31, 2024 | — |
| DEFA14A | Additional proxy material | Oct 3, 2024 | — |
| DEFA14A | Additional proxy material | Aug 21, 2024 | — |
| DEF 14A | Proxy statement | Aug 21, 2024 | Oct 2, 2024 |
| PRE 14A | Preliminary proxy statement | Aug 9, 2024 | Oct 2, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 18, 2024 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 14, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2023 | Jun 14, 2023 |
| DEFA14A | Additional proxy material | May 27, 2022 | — |
| DEFA14A | Additional proxy material | Apr 27, 2022 | — |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 9, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2021 | — |
| DEF 14A | Proxy statement | Apr 27, 2021 | Jun 10, 2021 |
| DEFA14A | Additional proxy material | Sep 3, 2020 | — |
| DEFA14A | Additional proxy material | Aug 31, 2020 | — |
| DEFA14A | Additional proxy material | Aug 28, 2020 | — |
| DEFA14A | Additional proxy material | Aug 26, 2020 | — |
| DEFA14A | Additional proxy material | Aug 3, 2020 | — |
| DEF 14A | Proxy statement | Aug 3, 2020 | Aug 31, 2020 |
| PRE 14A | Preliminary proxy statement | Jul 24, 2020 | Aug 31, 2020 |
| DEFA14A | Additional proxy material | Jun 18, 2020 | — |
| DEFA14A | Additional proxy material | May 19, 2020 | — |
| DEF 14A | Proxy statement | May 19, 2020 | Jun 30, 2020 |
| PRE 14A | Preliminary proxy statement | May 6, 2020 | Jun 30, 2020 |
| DEFA14A | Additional proxy material | Apr 24, 2019 | — |
| DEF 14A | Proxy statement | Apr 24, 2019 | Jun 6, 2019 |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- BNGO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1411690
- Former names
- BioNano Genomics, Inc (until Oct 20, 2021); Bionano Genomics, Inc (until Oct 20, 2021); BioNanomatrix Inc (until Mar 24, 2011)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Source: SEC EDGAR filings. This is company-reported data, not investment advice.